SANTA BARBARA, Calif., Sept. 8, 2022 /PRNewswire/ — Bexson Biomedical, Inc., a biopharmaceutical company focused on disrupting the $189 billion small molecule injectable market and enabling home health solutions, today announced that the Company’s management will be participating in the 2022 Jeffries Innovation in Mental Health Summit. Bexson’s Chief Executive Officer, Gregg Peterson…
